Brian C Schulte (Brian Schulte)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Chronic Kidney Disease

Drug Administration

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Caleb Hwang, Mark Agulnik, Brian C Schulte
Prices and Trends in FDA-Approved Medications for Sarcomas. Cancers 16 (8) (2024)
Brian C Schulte, Caleb Hwang, Andrew E Horvai, Timothee Olivier
When destiny doesn't pan out: Implications for the treatment of sarcomas after the agnostic approval of trastuzumab deruxtecan. Cancer (2024)
Caleb Hwang, Mark Agulnik, Brian C Schulte
Prices and Trends in FDA-Approved Medications for Sarcomas. Cancers 16 (8) (2024)
Shihong Zhang, R Graeme Black, Karan Kohli, Brian J Hayes, Cassandra Miller, Amanda L Koehne, Brett A Schroeder, Kraig Abrams, Brian C Schulte, Borislav A Alexiev, Amy B Heimberger, Ali Zhang, Weiqing Jing, Juliana Chi Kei Ng, Himaly Shinglot, Bernard Séguin, Alexander I Salter, Stanley R Riddell, Michael C Jensen, Stephen Gottschalk, Peter F Moore, Beverly Torok-Storb, Seth M Pollack
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model. Molecular cancer therapeutics 21 (6) (2022)